Test antigenico per COVID-19 SARS-CoV-2 | LumiraDx (Italia)
LumiraDx Instrument for Rapid Detection of SARS-CoV-2 Instrument for Rapid | Fisher Scientific
Test Covid 19 Ultima Generazione, Immunofluorescenza con lettura microfluidica - Farmacia Pescetto di Pegli, Genova
Beyond The Pandemic – Africa Health Business
Test point-of-care | LumiraDx (Italia)
LumiraDx bags CDSCO approval for COVID-19 antigen test
Coronavirus: Welsh NHS to adopt 12-minute testing kit - BBC News
Non riconoscono tre positivi su dieci”. L'atto d'accusa contro i test rapidi - la Repubblica
LumiraDx Expands its Cardiovascular Testing Portfolio with CE Marking of its NT-proBNP Test and new Exclusion Claim for its D-Dimer Test
LumiraDx Instrument for Rapid Detection of SARS-CoV-2 Instrument for Rapid | Fisher Scientific
LumiraDx SARS-CoV-2 Ag Test (48 Tests) | Africa Medical Supplies Platform
Rapid Antigen Test Approved in Italy, Japan & Brazil
LumiraDx launches C-Reactive Protein test to combat antimicrobial resistance in India, ET HealthWorld
A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care | medRxiv
LumiraDx riceve l'autorizzazione per il test antigenico SARS-CoV-2 in Giappone e Brasile; l'Italia raccomanda l'espansione del test antigenico basato su microfluidica
LumiraDx Antigen Test Supports Established Testing Concepts with Rapid and Accurate Results in Germany